Inactive Instrument

Aceto Corporation

Aceto Corporation Reports Earnings Results for the Second Quarter Ended December 31, 2018

February 20, 2019 at 07:01 am EST

Aceto Corporation announced earnings results for the second quarter ended December 31, 2018. For the second quarter, the company announced sales was USD 163.649 million compared to USD 171.229 million a year ago. Operating loss was USD 15.068 million compared to operating Income of USD 3.785 million a year ago. Net loss was USD 22.350 million compared to USD 13.864 million a year ago. Basic loss per share was USD 0.63 compared to USD 0.39 a year ago. For the half year, sales was USD 328.054 million compared to USD 356.484 million a year ago. Operating loss was USD 28.366 million compared to operating Income of USD 11.004 million a year ago. Net loss was USD 43.442 million compared to USD 13.410 million a year ago. Basic loss per share was USD 1.22 compared to USD 0.38 a year ago.

Latest news about Aceto Corporation

Actylis and Novo Nordisk Pharmatech Announce a Strategic Partnership for the Distribution of Benzalkonium Chloride in Targeted European Countries	Mar. 25	CI
Actylis Launches A New Cgmp Wfi Generation, Storage, and Distribution System with Additional Iso Class 7 Manufacturing Space	23-09-21	CI
Actylis Opens a 30,000Ft² cGMP Facility to Bolster its Innovative Api Manufacturing Capabilities	23-02-27	CI
Aceto Corporation acquired Talus Mineral Company and Biotron Laboratories, Inc.	22-03-01	CI
Aceto Corporation acquired A & C Bio Buffer Limited.	21-10-11	CI
Aceto Corporation acquired Cascade Chemistry.	21-06-01	CI
Aceto Corporation acquired an unknown majority stake in Finar Ltd.	21-05-16	CI
Aceto Strengthens Self-Manufacturing and Vaccine and Biopharmaceutical Offering with Acquisition of A&C	21-04-15	CI
Aceto Corporation acquired A&C.	21-04-14	CI
Aceto to Expand Bioreagent Offering to Support Growing Customer Demand in Biopharma and Cell Culture Manufacturing	21-03-15	CI
Aceto Corporation acquired IsleChem, LLC.	20-12-20	CI
Aceto Corporation's Equity Buyback announced on December 11, 2009, has expired.	20-05-30	CI
Aceto Corporation completed the acquisition of Syntor Fine Chemicals Limited.	20-04-16	CI
Aceto Corporation agreed to acquire Syntor Fine Chemicals Limited.	20-04-05	CI
Aceto Corporation Went Out of Business	19-10-01	CI
Second Motion for Exclusivity Period Extension Approved For Aceto Corporation	19-09-20	CI
Second Modified Joint Liquidation Plan and Disclosure Statement Approved for Aceto Corporation	19-09-18	CI
Motion for Asset Sale Approved for Aceto Corporation	19-09-04	CI
Motion for Asset Sale Filed by Aceto Corporation	19-08-12	CI
Disclosure Statement Approved on Interim Basis for Aceto Corporation	19-07-26	CI
Aceto Announces Management Changes	19-06-20	CI
Aceto Corporation Announces Executive Changes	19-06-18	CI
First Motion for Exclusivity Period Extension Approved For Aceto Corporation	19-06-18	CI
Joint Liquidation Plan and Disclosure Statement Filed by Aceto Corporation	19-06-17	CI
Aceto Corporation Announces the Termination of William C. Kennally, III as President and Chief Executive Officer of the Company	19-06-03	CI

Chart Aceto Corporation

Duration

Period

More charts

Company Profile

Tri Harbor Holdings Corp., also known as Aceto, is a United States-based virtual manufacturer engaged in supplying specialty materials. The Company is primarily engaged in supplying its materials to life sciences and advanced technology end markets. The Company operates its business operations in nine countries, and distributes over 1,100 chemical compounds used principally by the pharmaceutical, nutraceutical, agricultural, and specialty chemical industries.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+29.27%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+15.95%	240B
NOVARTIS AG	+9.38%	208B
ROCHE HOLDING AG	-7.32%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals